232 related articles for article (PubMed ID: 36070228)
21. Prognostic value of γ-aminobutyric acidergic synapse-associated signature for lower-grade gliomas.
Jiang H; Sun Z; Li F; Chen Q
Front Immunol; 2022; 13():983569. PubMed ID: 36405708
[TBL] [Abstract][Full Text] [Related]
22. Indoleamine 2,3-dioxygenase 1 is highly expressed in glioma stem cells.
Ozawa Y; Yamamuro S; Sano E; Tatsuoka J; Hanashima Y; Yoshimura S; Sumi K; Hara H; Nakayama T; Suzuki Y; Yoshino A
Biochem Biophys Res Commun; 2020 Apr; 524(3):723-729. PubMed ID: 32035622
[TBL] [Abstract][Full Text] [Related]
23. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
24. Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis.
Zhang Z; Shen X; Tan Z; Mei Y; Lu T; Ji Y; Cheng S; Xu Y; Wang Z; Liu X; He W; Chen Z; Chen S; Lv Q
Front Genet; 2022; 13():1053263. PubMed ID: 36712869
[No Abstract] [Full Text] [Related]
25. A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas.
Wu Y; Peng Z; Gu S; Wang H; Xiang W
Comput Math Methods Med; 2022; 2022():2558548. PubMed ID: 35186111
[TBL] [Abstract][Full Text] [Related]
26. The hypoxic peri-arteriolar glioma stem cell niche, an integrated concept of five types of niches in human glioblastoma.
Aderetti DA; Hira VVV; Molenaar RJ; van Noorden CJF
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):346-354. PubMed ID: 29684521
[TBL] [Abstract][Full Text] [Related]
27. TANK shapes an immunosuppressive microenvironment and predicts prognosis and therapeutic response in glioma.
Li S; Guo Y; Hu H; Gao N; Yan X; Zhou Q; Liu H
Front Immunol; 2023; 14():1138203. PubMed ID: 37215097
[TBL] [Abstract][Full Text] [Related]
28. Long noncoding RNA SNHG9 facilitates growth of glioma stem-like cells via miR-326/SOX9 axis.
Wang CJ; Chao CR; Zhao WF; Liu HM; Feng JS; Cui YX
J Gene Med; 2022 Jan; 24(1):e3334. PubMed ID: 33789359
[TBL] [Abstract][Full Text] [Related]
29. Identification of an Inflammatory Response-Related Gene Signature to Predict Survival and Immune Status in Glioma Patients.
Yan Z; Gao Y; Yu J; Shen Z; Bu X
J Immunol Res; 2022; 2022():8972730. PubMed ID: 35647198
[TBL] [Abstract][Full Text] [Related]
30. A novel chemokine-based signature for prediction of prognosis and therapeutic response in glioma.
Fan W; Wang D; Li G; Xu J; Ren C; Sun Z; Wang Z; Ma W; Zhao Z; Bao Z; Jiang T; Zhang Y
CNS Neurosci Ther; 2022 Dec; 28(12):2090-2103. PubMed ID: 35985661
[TBL] [Abstract][Full Text] [Related]
31. Role of glioma stem cells in promoting tumor chemo- and radioresistance: A systematic review of potential targeted treatments.
Agosti E; Zeppieri M; Ghidoni M; Ius T; Tel A; Fontanella MM; Panciani PP
World J Stem Cells; 2024 May; 16(5):604-614. PubMed ID: 38817336
[TBL] [Abstract][Full Text] [Related]
32. Delineating the cytogenomic and epigenomic landscapes of glioma stem cell lines.
Baronchelli S; Bentivegna A; Redaelli S; Riva G; Butta V; Paoletta L; Isimbaldi G; Miozzo M; Tabano S; Daga A; Marubbi D; Cattaneo M; Biunno I; Dalprà L
PLoS One; 2013; 8(2):e57462. PubMed ID: 23468990
[TBL] [Abstract][Full Text] [Related]
33. Identification and validation of an anoikis-associated gene signature to predict clinical character, stemness, IDH mutation, and immune filtration in glioblastoma.
Sun Z; Zhao Y; Wei Y; Ding X; Tan C; Wang C
Front Immunol; 2022; 13():939523. PubMed ID: 36091049
[TBL] [Abstract][Full Text] [Related]
34. T cells enhance stem-like properties and conditional malignancy in gliomas.
Irvin DK; Jouanneau E; Duvall G; Zhang XX; Zhai Y; Sarayba D; Seksenyan A; Panwar A; Black KL; Wheeler CJ
PLoS One; 2010 Jun; 5(6):e10974. PubMed ID: 20539758
[TBL] [Abstract][Full Text] [Related]
35. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
[TBL] [Abstract][Full Text] [Related]
36. Extracellular Vesicles Secreted by Glioma Stem Cells Are Involved in Radiation Resistance and Glioma Progression.
Ma C; Nguyen HPT; Jones JJ; Stylli SS; Whitehead CA; Paradiso L; Luwor RB; Areeb Z; Hanssen E; Cho E; Putz U; Kaye AH; Morokoff AP
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269915
[TBL] [Abstract][Full Text] [Related]
37. MDM2 Degrades Deacetylated Nucleolin Through Ubiquitination to Promote Glioma Stem-Like Cell Enrichment for Chemotherapeutic Resistance.
Ko CY; Lin CH; Chuang JY; Chang WC; Hsu TI
Mol Neurobiol; 2018 Apr; 55(4):3211-3223. PubMed ID: 28478507
[TBL] [Abstract][Full Text] [Related]
38. Glioma-associated stem cells: a novel class of tumor-supporting cells able to predict prognosis of human low-grade gliomas.
Bourkoula E; Mangoni D; Ius T; Pucer A; Isola M; Musiello D; Marzinotto S; Toffoletto B; Sorrentino M; Palma A; Caponnetto F; Gregoraci G; Vindigni M; Pizzolitto S; Falconieri G; De Maglio G; Pecile V; Ruaro ME; Gri G; Parisse P; Casalis L; Scoles G; Skrap M; Beltrami CA; Beltrami AP; Cesselli D
Stem Cells; 2014 May; 32(5):1239-53. PubMed ID: 24375787
[TBL] [Abstract][Full Text] [Related]
39. A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy.
Zeng Z; Hu C; Ruan W; Zhang J; Lei S; Yang Y; Peng P; Pan F; Chen T
Front Immunol; 2022; 13():1001381. PubMed ID: 36159801
[TBL] [Abstract][Full Text] [Related]
40. Nanomedicines Targeting Glioma Stem Cells.
Sabu A; Liu TI; Ng SS; Doong RA; Huang YF; Chiu HC
ACS Appl Mater Interfaces; 2023 Jan; 15(1):158-181. PubMed ID: 35544684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
